Misplaced Pages

Hymecromone: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 12:44, 9 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').← Previous edit Latest revision as of 16:14, 21 October 2024 edit undoJWBE (talk | contribs)Extended confirmed users10,111 edits removed Category:Phenols; added Category:Hydroxyarenes using HotCat 
(18 intermediate revisions by 15 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{more citations needed|date=January 2021}}
{{Drugbox {{Drugbox
| Watchedfields = changed
| verifiedrevid = 415659048 | verifiedrevid = 443864211
| IUPAC_name = 7-Hydroxy-4-methylchromen-2-one | IUPAC_name = 7-Hydroxy-4-methylchromen-2-one
| image = Hymecromone.png | image = Hymecromone.png
| synonyms = 4-Methylumbelliferone
<!--Clinical data-->
| CASNo_Ref = {{cascite|correct|CAS}}
| tradename =
| Drugs.com = {{drugs.com|international|hymecromone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 90-33-5
| ATC_prefix = A05
| ATC_suffix = AX02
| PubChem = 5280567
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB07118
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4444190 | ChemSpiderID = 4444190
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3T5NG4Q468 | UNII = 3T5NG4Q468
| KEGG_Ref = {{keggcite|correct|kegg}}
| InChI = 1/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3
| KEGG = D00170
| smiles = O=C/2Oc1cc(O)ccc1\C(=C\2)C
| ChEBI_Ref = {{ebicite|correct|EBI}}
| InChIKey = HSHNITRMYYLLCV-UHFFFAOYAZ
| ChEBI = 17224
| ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 12208 | ChEMBL = 12208
<!--Chemical data-->
| C=10 | H=8 | O=3
| smiles = CC1=CC(=O)OC2=C1C=CC(=C2)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3 | StdInChI = 1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HSHNITRMYYLLCV-UHFFFAOYSA-N | StdInChIKey = HSHNITRMYYLLCV-UHFFFAOYSA-N
| synonyms = 4-Methylumbelliferone
| CAS_number = 90-33-5
| ATC_prefix = A05
| ATC_suffix = AX02
| ChEBI = 17224
| PubChem = 5280567
| DrugBank = DB07118
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00170
| C=10|H=8|O=3
| molecular_weight = 176.17 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}} }}


'''Hymecromone''' (4-methylumbelliferone) is a drug used in ] therapy. It is used as ] and ] drugs and as a standard for the fluorometric determination of enzyme activity. '''Hymecromone''' (4-methylumbelliferone) is a drug used in ] therapy. It is used as ] and ] drugs and as a standard for the fluorometric determination of enzyme activity.<ref name="pmid7390976">{{cite journal | vauthors = Yang Y, Hamaguchi K | title = Hydrolysis of 4-methylumbelliferyl N-acetyl-chitotrioside catalyzed by hen and turkey lysozymes. pH dependence of the kinetics constants | journal = Journal of Biochemistry | volume = 87 | issue = 4 | pages = 1003–14 | date = April 1980 | pmid = 7390976 | doi = 10.1093/oxfordjournals.jbchem.a132833 }}</ref>


Hymecromone is crystalline solid with a melting point of 194-195 °C. It is soluble in ] and ]. Hymecromone is a crystalline solid with a melting point of 194–195&nbsp;°C. It is soluble in ] and ].

==See also==
*]
*]

==References==
{{Reflist}}


{{Bile and liver therapy}} {{Bile and liver therapy}}
Line 52: Line 67:


] ]
] ]


{{gastrointestinal-drug-stub}}


{{gastrointestinal-drug-stub}}
]
]